Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis — Gianvito Martino (1997) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis
Shared by
Massimo Filippi
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis
Article
1997
en
Authors
+6 more
GM
Gianvito Martino
AC
Antonella Consiglio
DF
Diego Franciotta
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2019
Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis
Claudia Mara Ribeiro
,
Sayonara Rangel Oliveira
,
Daniela Frizon Alfieri
,
Tamires Flauzino
,
Damacio Ramón Kaimen-Maciel
,
Andréa Name Colado Simão
,
Michael Maes
,
Edna Maria Vissoci Reiche
Article
2019
Coagulation activation and cerebral hypoperfusion in relapsing-remitting multiple sclerosis
Tatiana Koudriavtseva
,
Silvana Zannino
,
Massimo Filippi
,
Antonio Cortese
,
Carlo Piantadosi
,
Caterina Lapucci
,
Marco Fiorelli
,
Diana Giannarelli
,
Chiara Mandoj
,
Annunziata Stefanile
,
Lorenzo Conti
,
Marco Salvetti
,
Matilde Inglese
Article
2014
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis
Per Soelberg Sørensen
,
Steen Lisby
,
Richard Grove
,
Frederick J. Derosier
,
Steve Shackelford
,
Eva Havrdová
,
Jelena Drulović
,
Massimo Filippi
Article
2012
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis
Maria A. Rocca
,
Paola Valsasina
,
Vittorio Martinelli
,
Paolo Misci
,
Andrea Falini
,
Gıancarlo Comı
,
Massimo Filippi
Article
2001
Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
O. E. Mikovа
,
R. Yakimova
,
E. Bosmans
,
Günter Kenis
,
Michael Maes
Discussion(0)
No comments yet. Be the first to comment.